About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Screening for NDM-1 Superbug in France

by Rathi Manohar on August 18, 2010 at 8:44 PM
 Screening for NDM-1 Superbug in France

The NDM-1 bacterium, an antibiotic-resistant superbug has created a panic situation and France has reacted by starting a screening process on patients, reported a medical watchdog.

Patients who have been treated in a foreign hospital and are being transferred to a French hospital for further treatment will be tested for the germ, he said.

Advertisement

"The French medical authorities will shortly announce that all patients who have been hospitalised abroad, regardless of the country, and repatriated to a French hospital, will be screened for NDM-1 bacteria," said Patrice Nordmann, a professor at the National Institute of Health and Medical Research (Inserm) who specialises in antibiotic resistance.

"Recommendations will be made in the near future that will outline these measures," he told AFP by phone.

Nordmann, an advisor to the French health ministry, said his team had already developed a test for the NDM-1 germ.
Advertisement

He added that France had a long-established practice of testing intensive-care patients for antibiotic-resistant strains. Patients with the bacteria are then isolated to prevent infection to others.

The superbug comprises a bacterium containing an enzyme gene called New Delhi metallo-lactamase-1 (NDM-1) that makes it impervious to treatment by almost all antibiotics.

These include drugs known as carbapenems, which are often used as a last resort.

The alarm was sounded last week by a British journal, The Lancet Infectious Diseases.

Researchers said they had identified dozens of cases among Britons who had travelled to South Asia for medical tourism.

Health tourists risked infection and the superbug could spread, they warned.

India's medical establishment reacted furiously to the study, accusing it of seeking to tar a fast-growing business.

Rich-world patients are flocking to India for operations ranging from facelifts to fertility treatments and open-heart surgery that cost in some cases only half that of western Europe.

On Friday, Brussels officials said a Belgian man became the first known fatality from NDM-1. The unnamed man had been hospitalised in Pakistan for a leg injury caused by a car accident, and died after being repatriated to a hospital in Belgium.

Source: AFP
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Environmental Health

Can Kitchen Spices & Indoor Plants be Harmful?
Kitchen spices like nutmeg and poppy seeds, when ingested in excess, as well as indoor ornamental plants, cause negative health issues.
Groundbreaking Study Forecasts 2023 as Hottest Year on Record
As global warming accelerates, the need for immediate and ongoing action to mitigate climate change's catastrophic consequences becomes imperative.
How Forever Chemicals Lead to Delayed Puberty?
Forever chemicals or per- and polyfluoroalkyl substances (PFAS) exposure in children, may cause them to mature later during puberty.
Carbon Footprint of a Hospital Bed Calculated
To achieve more substantial reductions in emissions, hospital sustainability efforts must extend their focus beyond the surface.
Most Parents Report Children Facing Poor Air Quality
Most parents in Canada support moving school activities indoors to protect children from poor air quality.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Screening for NDM-1 Superbug in France Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests